Insmed, Inc. (INSM)
111.12
+2.53
(+2.33%)
USD |
NASDAQ |
Oct 02, 16:00
111.44
+0.32
(+0.29%)
After-Hours: 20:00
Insmed Market Cap : 24.26B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 24.26B |
| October 01, 2026 | 23.70B |
| September 30, 2026 | 24.91B |
| September 29, 2026 | 25.24B |
| September 28, 2026 | 25.69B |
| September 25, 2026 | 25.72B |
| September 24, 2026 | 26.53B |
| September 23, 2026 | 25.83B |
| September 22, 2026 | 26.37B |
| September 21, 2026 | 26.41B |
| September 18, 2026 | 26.19B |
| September 17, 2026 | 27.06B |
| September 16, 2026 | 26.76B |
| September 15, 2026 | 26.18B |
| September 14, 2026 | 27.35B |
| September 11, 2026 | 28.25B |
| September 10, 2026 | 27.78B |
| September 09, 2026 | 28.11B |
| September 08, 2026 | 27.26B |
| September 04, 2026 | 27.57B |
| September 03, 2026 | 27.65B |
| September 02, 2026 | 27.64B |
| September 01, 2026 | 26.52B |
| August 31, 2026 | 26.59B |
| August 28, 2026 | 25.88B |
| Date | Value |
|---|---|
| August 27, 2026 | 26.50B |
| August 26, 2026 | 27.15B |
| August 25, 2026 | 27.04B |
| August 24, 2026 | 27.06B |
| August 21, 2026 | 27.45B |
| August 20, 2026 | 27.30B |
| August 19, 2026 | 28.52B |
| August 18, 2026 | 28.04B |
| August 17, 2026 | 28.01B |
| August 14, 2026 | 27.01B |
| August 13, 2026 | 27.58B |
| August 12, 2026 | 28.87B |
| August 11, 2026 | 28.94B |
| August 10, 2026 | 29.41B |
| August 07, 2026 | 28.62B |
| August 06, 2026 | 28.93B |
| August 05, 2026 | 21.61B |
| August 04, 2026 | 21.56B |
| August 03, 2026 | 21.49B |
| July 31, 2026 | 21.35B |
| July 30, 2026 | 21.97B |
| July 29, 2026 | 22.33B |
| July 28, 2026 | 22.55B |
| July 27, 2026 | 22.68B |
| July 24, 2026 | 23.15B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Biogen, Inc. | 32.48B |
| Gilead Sciences, Inc. | 179.62B |
| United Therapeutics Corp. | 23.12B |
| Vertex Pharmaceuticals, Inc. | 127.87B |
Market Cap Related Metrics
| PS Ratio | 20.96 |
| Price to Book Value | 32.02 |
| Price | 111.12 |
| Earnings Yield | -3.69% |